Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 505 | 0 | 367 | 781 | 548 |
| Gross Profit | 505 | N/A | 367 | 781 | 548 |
| Operating Expenses | 15,734 | 13,345 | 10,411 | 10,212 | 8,618 |
| Operating Income | -15,229 | -13,345 | -10,044 | -9,431 | -8,070 |
| Other Income | 799 | 918 | 1,028 | 936 | 482 |
| Pre-tax Income | -14,430 | -12,427 | -9,016 | -8,495 | -7,588 |
| Net Income Continuous | -14,430 | -12,427 | -9,016 | -8,495 | -7,588 |
| Net Income | $-14,430 | $-12,427 | $-9,016 | $-8,495 | $-7,588 |
| EPS Basic Total Ops | -0.60 | -0.51 | -0.37 | 3.48 | -0.38 |
| EPS Basic Continuous Ops | -0.60 | -0.51 | -0.37 | 3.48 | -0.38 |
| EPS Diluted Total Ops | -0.60 | -0.51 | -0.37 | 3.48 | -0.38 |
| EPS Diluted Continuous Ops | -0.60 | -0.51 | -0.37 | 3.48 | -0.38 |
| EBITDA(a) | $-15,321 | $-13,404 | $-10,244 | $-9,656 | $-7,931 |